NCT00837265 2024-04-03NEUGR-002Teva Branded Pharmaceutical Products R&D, Inc.Phase 2/3 Completed334 enrolled 16 charts
NCT00151242 2017-09-20Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid LeukemiaUniversity of UlmPhase 2/3 Completed920 enrolled